{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:26:16Z","timestamp":1740122776031,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100015615","name":"National Drug Abuse Treatment Clinical Trials Network","doi-asserted-by":"publisher","award":["(K02 DA033139 and R01DA032290)"],"award-info":[{"award-number":["(K02 DA033139 and R01DA032290)"]}],"id":[{"id":"10.13039\/100015615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10461-024-04526-5","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T04:43:15Z","timestamp":1730868195000},"page":"4046-4051","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Examining the Accuracy of Self-Reported Antiretroviral Therapy Adherence Using a Visual Analog Scale Among Opioid-Dependent People Living with HIV"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7742-2186","authenticated-orcid":false,"given":"Jude","family":"Ssenyonjo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Copenhaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"key":"4526_CR1","unstructured":"UNAIDS. The path that ends aids 2023 unaids global aids update. 2022."},{"key":"4526_CR2","unstructured":"NIDA. 2023, A., Only 1 in 5 U.S. adults with opioid use disorder received medications to treat it in 2021. 2023."},{"key":"4526_CR3","unstructured":"(CDC), C.f.D.C.a.P., HIV Infection and HIV-Associated Behaviors Among Persons Who Inject Drugs \u2014 23 Metropolitan Statistical Areas, United States,. 2018. MMWR 2018."},{"issue":"2","key":"4526_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/QAI.0b013e3181ca48bf","volume":"54","author":"TR Glass","year":"2010","unstructured":"Glass TR, et al. Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2010;54(2):197\u2013203.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"4526_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11904-011-0093-5","volume":"8","author":"A Gonzalez","year":"2011","unstructured":"Gonzalez A, Barinas J, O\u2019Cleirigh C. Substance use: impact on adherence and HIV medical treatment. Curr HIV\/AIDS Rep. 2011;8(4):223\u201334.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"4526_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12889-018-6314-8","volume":"19","author":"AR Bazzi","year":"2019","unstructured":"Bazzi AR, et al. Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions. BMC Public Health. 2019;19(1):31.","journal-title":"BMC Public Health"},{"issue":"8","key":"4526_CR7","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/cid\/ciw416","volume":"63","author":"AJ Low","year":"2016","unstructured":"Low AJ, et al. Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and Meta-analysis. Clin Infect Dis. 2016;63(8):1094\u2013104.","journal-title":"Clin Infect Dis"},{"key":"4526_CR8","unstructured":"HIV\/AIDS. J.U.N.P.o. and J.U.N.P.o.H.A.J.G. Unaids, 90-90-90: an ambitious treatment target to help end the AIDS epidemic. 2014."},{"key":"4526_CR9","doi-asserted-by":"crossref","unstructured":"Cohen MS et al. Prevention of HIV-1 Infection with Early Antiretroviral Therapy. 2011. 365(6): pp. 493\u2013505.","DOI":"10.1056\/NEJMc1110588"},{"issue":"2","key":"4526_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/COH.0b013e32834f5cf2","volume":"7","author":"MS Cohen","year":"2012","unstructured":"Cohen MS, McCauley M, Gamble TR. HIV treatment as prevention and HPTN 052. Curr Opin HIV AIDS. 2012;7(2):99\u2013105.","journal-title":"Curr Opin HIV AIDS"},{"issue":"6","key":"4526_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen MS, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493\u2013505.","journal-title":"N Engl J Med"},{"issue":"5","key":"4526_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1001\/jama.2018.21167","volume":"321","author":"RW Eisinger","year":"2019","unstructured":"Eisinger RW, Dieffenbach CW, Fauci AS. HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. JAMA. 2019;321(5):451\u20132.","journal-title":"JAMA"},{"issue":"1","key":"4526_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4102\/sajhivmed.v19i1.915","volume":"19","author":"NE Davies","year":"2018","unstructured":"Davies NE, et al. Guidelines to support HIV-affected individuals and couples to achieve pregnancy safely: update 2018. South Afr J HIV Med. 2018;19(1):1\u201326.","journal-title":"South Afr J HIV Med"},{"key":"4526_CR14","doi-asserted-by":"crossref","unstructured":"Hiv TL. U\u2009=\u2009U taking off in 2017. 2017. p. e475.","DOI":"10.1016\/S2352-3018(17)30183-2"},{"issue":"3","key":"4526_CR15","doi-asserted-by":"publisher","first-page":"N1","DOI":"10.1097\/QAD.0000000000002098","volume":"33","author":"SC Tobin","year":"2019","unstructured":"Tobin SC. U\u2009=\u2009U gains strength with release of PARTNER2 data. Aids. 2019;33(3):N1.","journal-title":"Aids"},{"issue":"3","key":"4526_CR16","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/clinchem\/hvz010","volume":"66","author":"RR Patel","year":"2020","unstructured":"Patel RR, Curoe KA, Chan PA. Undetectable equals untransmittable: a game changer for HIV prevention. Clin Chem. 2020;66(3):406\u20137.","journal-title":"Clin Chem"},{"issue":"6","key":"4526_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/1545109709352884","volume":"8","author":"SC Kalichman","year":"2009","unstructured":"Kalichman SC, et al. A simple single-item rating scale to measure medication adherence: further evidence for convergent validity. J Int Assoc Physicians AIDS Care (Chic). 2009;8(6):367\u201374.","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"issue":"12","key":"4526_CR18","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1089\/apc.2005.19.833","volume":"19","author":"SC Kalichman","year":"2005","unstructured":"Kalichman SC, et al. Pillboxes and antiretroviral adherence: prevalence of use, perceived benefits, and implications for electronic medication monitoring devices. AIDS Patient Care STDS. 2005;19(12):833\u20139.","journal-title":"AIDS Patient Care STDS"},{"issue":"7","key":"4526_CR19","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1086\/521250","volume":"45","author":"ML Petersen","year":"2007","unstructured":"Petersen ML, et al. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis. 2007;45(7):908\u201315.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4526_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10461-006-9078-6","volume":"10","author":"JM Simoni","year":"2006","unstructured":"Simoni JM, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227\u201345.","journal-title":"AIDS Behav"},{"issue":"7","key":"4526_CR21","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/01.mlr.0000129496.05898.02","volume":"42","author":"MC Garber","year":"2004","unstructured":"Garber MC, et al. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care. 2004;42(7):649\u201352.","journal-title":"Med Care"},{"issue":"5","key":"4526_CR22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1310\/hct1205-244","volume":"12","author":"A Buscher","year":"2011","unstructured":"Buscher A, et al. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naive, HIV patients. HIV Clin Trials. 2011;12(5):244\u201354.","journal-title":"HIV Clin Trials"},{"issue":"5","key":"4526_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1310\/hct1205-244","volume":"12","author":"A Buscher","year":"2011","unstructured":"Buscher A, et al. Validity of Self-Report measures in assessing antiretroviral adherence of newly diagnosed, HAART-Na\u00efve, HIV patients. HIV Clin Trial. 2011;12(5):244\u201354.","journal-title":"HIV Clin Trial"},{"issue":"8","key":"4526_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/apc.2009.0021","volume":"23","author":"S Martin","year":"2009","unstructured":"Martin S, et al. A comparison of adherence assessment methods utilized in the United States: perspectives of researchers, HIV-infected children, and their caregivers. AIDS Patient Care STDS. 2009;23(8):593\u2013601.","journal-title":"AIDS Patient Care STDS"},{"issue":"5","key":"4526_CR25","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1371\/journal.pmed.0050109","volume":"5","author":"GP Bisson","year":"2008","unstructured":"Bisson GP, et al. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Med. 2008;5(5):e109.","journal-title":"PLoS Med"},{"issue":"3","key":"4526_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4103\/1947-2714.109196","volume":"5","author":"B Achappa","year":"2013","unstructured":"Achappa B, et al. Adherence to antiretroviral therapy among people living with HIV. N Am J Med Sci. 2013;5(3):220\u20133.","journal-title":"N Am J Med Sci"},{"issue":"1","key":"4526_CR27","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1186\/1471-2458-14-1035","volume":"14","author":"RZ Sangeda","year":"2014","unstructured":"Sangeda RZ, et al. Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings. BMC Public Health. 2014;14(1):1035.","journal-title":"BMC Public Health"},{"issue":"1","key":"4526_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/08897077.2011.540466","volume":"32","author":"MM Copenhaver","year":"2011","unstructured":"Copenhaver MM, et al. Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users. Subst Abus. 2011;32(1):16\u201326.","journal-title":"Subst Abus"},{"issue":"11","key":"4526_CR29","doi-asserted-by":"publisher","first-page":"817","DOI":"10.7326\/0003-4819-156-11-201206050-00419","volume":"156","author":"MA Thompson","year":"2012","unstructured":"Thompson MA, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med. 2012;156(11):817\u201333. w-284, w-285, w-286, w-287, w-288, w-289, w-290, w-291, w-292, w-293, w-294.","journal-title":"Ann Intern Med"},{"issue":"2","key":"4526_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1310\/JFXH-G3X2-EYM6-D6UG","volume":"5","author":"TP Giordano","year":"2004","unstructured":"Giordano TP, et al. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5(2):74\u20139.","journal-title":"HIV Clin Trials"},{"key":"4526_CR31","unstructured":"RStudio Team -, RStudio P. RStudio: Integrated Development Environment for R. 2020."},{"issue":"7","key":"4526_CR32","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/jclp.20584","volume":"65","author":"CJ Hopwood","year":"2009","unstructured":"Hopwood CJ, et al. A comparison of latino and anglo socially desirable responding. J Clin Psychol. 2009;65(7):769\u201380.","journal-title":"J Clin Psychol"},{"issue":"6","key":"4526_CR33","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s10865-016-9770-6","volume":"39","author":"DJ Finitsis","year":"2016","unstructured":"Finitsis DJ, et al. Visual analogue scale (VAS) measurement of antiretroviral adherence in people living with HIV (PLWH): a meta-analysis. J Behav Med. 2016;39(6):1043\u201355.","journal-title":"J Behav Med"},{"issue":"8","key":"4526_CR34","doi-asserted-by":"publisher","first-page":"e0203032","DOI":"10.1371\/journal.pone.0203032","volume":"13","author":"W Da","year":"2018","unstructured":"Da W, et al. Evaluation of self-report adherence measures and their associations with detectable viral load among people living with HIV (PLHIV) in China. PLoS ONE. 2018;13(8):e0203032.","journal-title":"PLoS ONE"},{"issue":"5","key":"4526_CR35","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11904-021-00568-9","volume":"18","author":"LB Whiteley","year":"2021","unstructured":"Whiteley LB, et al. A review of interventions to enhance HIV Medication Adherence. Curr HIV\/AIDS Rep. 2021;18(5):443\u201357.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"4","key":"4526_CR36","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10461-009-9555-9","volume":"14","author":"CJ Gill","year":"2010","unstructured":"Gill CJ, et al. Importance of dose timing to achieving undetectable viral loads. AIDS Behav. 2010;14(4):785\u201393.","journal-title":"AIDS Behav"},{"issue":"2","key":"4526_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10461-006-9133-3","volume":"11","author":"CR Pearson","year":"2007","unstructured":"Pearson CR, et al. Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues. AIDS Behav. 2007;11(2):161\u201373.","journal-title":"AIDS Behav"},{"issue":"1","key":"4526_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11096-013-9865-x","volume":"36","author":"A Lehmann","year":"2014","unstructured":"Lehmann A, et al. Assessing medication adherence: options to consider. Int J Clin Pharm. 2014;36(1):55\u201369.","journal-title":"Int J Clin Pharm"},{"issue":"12","key":"4526_CR39","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2165\/11537400-000000000-00000","volume":"28","author":"L Shi","year":"2010","unstructured":"Shi L, et al. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. PharmacoEconomics. 2010;28(12):1097\u2013107.","journal-title":"PharmacoEconomics"},{"issue":"5","key":"4526_CR40","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1177\/0193945912439251","volume":"34","author":"J Dunbar-Jacob","year":"2012","unstructured":"Dunbar-Jacob J, et al. Accuracy of measures of medication adherence in a cholesterol-lowering regimen. West J Nurs Res. 2012;34(5):578\u201397.","journal-title":"West J Nurs Res"},{"issue":"4","key":"4526_CR41","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1089\/aid.2014.0229","volume":"31","author":"JR Castillo-Mancilla","year":"2015","unstructured":"Castillo-Mancilla JR, et al. Short communication: Tenofovir diphosphate in dried blood spots as an objective measure of adherence in HIV-infected women. AIDS Res Hum Retroviruses. 2015;31(4):428\u201332.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"4526_CR42","unstructured":"Warne P et al. Utility of dried blood spot-derived ARV biomarkers as an objective measure of treatment adherence in South Africa. in IAPAC 10th International Conference on HIV Treatment and Prevention Adherence. 2015."},{"issue":"6","key":"4526_CR43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3810\/pgm.2011.11.2502","volume":"123","author":"BH McCarberg","year":"2011","unstructured":"McCarberg BH. A critical Assessment of Opioid Treatment Adherence using urine drug testing in Chronic Pain Management. Postgrad Med. 2011;123(6):124\u201331.","journal-title":"Postgrad Med"},{"key":"4526_CR44","doi-asserted-by":"crossref","unstructured":"Cook P et al. Practical and Analytic Issues in the Electronic Assessment of Adherence. 2012. 34(5): pp. 598\u2013620.","DOI":"10.1177\/0193945911427153"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-024-04526-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-024-04526-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-024-04526-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T13:09:29Z","timestamp":1732540169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-024-04526-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["4526"],"URL":"https:\/\/doi.org\/10.1007\/s10461-024-04526-5","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"type":"print","value":"1090-7165"},{"type":"electronic","value":"1573-3254"}],"subject":[],"published":{"date-parts":[[2024,11,6]]},"assertion":[{"value":"30 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}